Avalet 20 mg (Avatrombopag) is a revolutionary oral medication designed to treat thrombocytopenia (low platelet count) in adults with chronic liver disease (CLD) who are scheduled to undergo medical or dental procedures. Avatrombopag, the active ingredient in Avalet, is a thrombopoietin receptor agonist that stimulates platelet production in the bone marrow, helping to increase platelet counts and reduce the risk…
Abeclib-150mg, powered by Abemaciclib, is a cutting-edge medication designed to treat advanced Treatment for Breast Cancer. This powerful drug, part of the CDK4/6 inhibitor class, works by targeting and blocking certain proteins in cancer cells, stopping their growth and division. It is specifically approved for hormone receptor-positive (HR+) and HER2-negative advanced breast cancer, either as a standalone treatment or combined…
Acalabrutinib, marketed under the brand name Acaluxen 100mg, is a breakthrough medication used in the treatment of specific Blood Cancer therapy, including mantle cell lymphoma (MCL) and chronic lymphocytic leukaemia (CLL). As a second-generation Bruton’s tyrosine kinase (BTK) inhibitor, Acalabrutinib works by blocking the activity of BTK, a protein that contributes to the growth and survival of cancer cells. This…
Afanix 40 Mg, containing the active ingredient Afatinib, is a powerful medication used in the treatment of non-small cell lung cancer (NSCLC). It belongs to the group of medications known as tyrosine kinase inhibitors (TKIs) that target and block specific proteins responsible for cancer cell growth. This makes Afanix 40 Mg an essential treatment option for patients with Medication Of…
Alecnib 150 Mg contains Alectinib, a highly effective oral medication designed to treat ALK-positive Non Small Cell Lung Cancer Treatment (NSCLC). Alectinib is a next-generation tyrosine kinase inhibitor (TKI) specifically engineered to block the action of anaplastic lymphoma kinase (ALK), a protein responsible for cancer cell growth in certain lung cancers. Alecnib has proven to be a breakthrough treatment for…
Looking for an effective treatment for renal cell carcinoma (RCC)? Axinix (Axitinib 1mg / 5mg) is a highly effective oral medication designed to help treat advanced or metastatic kidney cancer. If you're seeking a targeted therapy that works to slow cancer progression and improve survival outcomes, Axinix may be the solution you've been looking for. This powerful drug inhibits the…
Axinix 5 mg contains Axitinib , a potent oral medication specifically developed to treat advanced renal cell carcinoma (RCC) , a type of kidney cancer. Axitinib belongs to the class of drugs known as tyrosine kinase inhibitors (TKIs), which work by blocking the proteins that encourage cancer cells to grow and spread. Axinix is often used in cases where other…
Baricinix 4 mg (baricitinib) is a powerful oral medication designed to treat moderate to severe rheumatoid arthritis (RA) in adults who have not responded well to other treatments. Baricitinib, the active ingredient in Baricinix, is a Janus kinase (JAK) inhibitor, which reduces inflammation and prevents the immune system from attacking the joints. Additionally, Baricinix 4 mg has been approved for…
Baricinix 4 mg and 2 mg , powered by Baricitinib , is a breakthrough oral medication used to treat moderate to severe Therapy for rheumatoid arthritis and COVID-19 complications in certain hospitalized patients. As a Janus kinase (JAK) inhibitor, Baricinix targets specific enzymes that cause inflammation in autoimmune diseases like rheumatoid arthritis. It has recently been approved for managing severe…
Barigen 4 Mg, containing Baricitinib, is a powerful oral medication designed to treat moderate to severe Therapy for Rheumatoid Arthritis and certain complications of COVID-19. Baricitinib belongs to the class of drugs known as Janus kinase (JAK) inhibitors, which target the inflammation processes that cause joint damage and pain in autoimmune conditions. It also plays a critical role in reducing…
Barinib 2 mg (baricitinib) is an innovative oral medication designed to treat moderate to severe rheumatoid arthritis (RA) in adults who have not responded well to other treatments. The active ingredient, Baricitinib, is a Janus kinase (JAK) inhibitor that helps reduce inflammation by targeting specific enzymes responsible for the overactive immune response in rheumatoid arthritis. Barinib 2 mg offers an…
Briganix 180 mg (Brigatinib) is a cutting-edge oral medication designed to treat ALK-positive non-small cell lung cancer (NSCLC) in adults. Brigatinib is a next-generation tyrosine kinase inhibitor (TKI) that targets the abnormal anaplastic lymphoma kinase (ALK) gene mutation, a key driver of cancer cell growth in ALK-positive lung cancer. This medication is particularly effective for patients whose cancer has progressed…
